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     A 53 years old man complaining productive cough and dyspnea admitted to a hos-
pital on 8th March, 1982. Chest X-ray showed the fine granular shadow through out 
lung fields. Arterial blood gas tensions were PO2 31 torr, PCO2 27 torr and AaDO2 86 
torr at pH 7.45. Transbronchial lung biopsy was performed and the microscopic findings 
of which showed eosinophilic, PAS positive granular materials filled in the intraalveolar 
space and the swelling of the alveolar lining cells. The patient was diagnosed as pulmo-
nary alveolar proteinosis and was saved by bronchoalveolar lavage with the aid of extra-
corporeal circulation. Histochemical and electron microscopic observation and biochemi-
cal analysis were performed, and it was suggested that the materials accumulated in the 
intraalveolar space were mostly originated from the lung surfactant secreted by the pul-
monary alveolar cells type II.
INTRODUCTION
     Pulmonary alveolar proteinosis is the disease in which eosinophilic and PAS-stain-
able granular materials accumulate in the alveoli. This disease was first reported by 
ROSEN, CASTLEMAN and LIEBOWI) in 1958. In Japan, OKA et al.2) reported the first 
case in 1960, and a total of 79 cases have been found out until 19793). 
     We have experienced a case with pulmonary alveolar proteinosis complicated with 
silicosis and pulmonary tubercurosis. This patient was saved by bronchoalveolar lavage 
(BAL) with the aid of extracorporeal circulation. During the treatment, we have carried 
out histochemical and electron microscopic observations on biopsied lung and the bron-
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choalveolar lavage fluid (BALF), and also analysed lipids in BALF. The results thus 
obtained are reported and discussed in this paper. 
              DESCRIPTION OF THE C SE 
     Patient : 53 years old man 
     Chief complaint : dyspnea 
     Family history : unremarkable 
     Past history : The patient worked for a tunnel construction from 1949 to 1974. In 
Nov. 1979, productive cough and fever developed. The sputum was found to be positive 
to tubercle bacilli, and he was diagnosed as silicotic pulmonary tuberculosis. After 2 
years treatment with a combination of EB, INH and RFP, he has been under therapy 
with INH alone since Nov. 1981. 
     Present illness : Exertional dyspnea, cough and sputum aggravated since around 
Aug. 1981. Since Feb. 1982, he became incapable of looking after himself because of 
dyspnea, thus he was admitted to a hospital on 8th March, 1982. Chest X-ray (Fig. 1) 
showed the fine granular shadow diffused bilaterally from the hilar region to the middle 
and the lower lung fields. Air bronchogram was also noted. Arterial blood gas analysis 
showed pH 7.45, P02 31 torr, PCO2 27 torr, and AaDO2 86 torr, indicating marked 
hypoxia, hypocapnia and high AaDO2. Transbronchial lung biopsy (TBLB) was per-
formed, and the patient was hospitalized to the Department of Internal Medicine, Medical 
College of Oita under a diagnosis of pulmonary alveolar proteinosis on 20th April, 1982. 
     Physical examinations : The patient was of averagely build and moderately nour-
ished. Anemia and jaundice were absent, but clubbed fingers and cyanosis were present. 
The blood pressure was 124/90 mmHg. The pulse was 117 per minute and regular. 
The respiration was 28 per minute and regular. Physical examination of the chest revealed 
the presence of moist rales over the entire lung fields. Heart sounds were clear. The 
abdomen was flat, and the liver and the spleen were not palpable. Superficial lymph 
nodes were not swollen. There was no edema in the lower extremities. Tendon reflex 
was normal, and other neurological examinations showed no abnormality. 
     Laboratory reports (Table 1) : Blood analysis showed slightly increasing number of 
RBC. Biochemical examination showed LDH to be increased to 1,430 IU/1 and GOT to 
96 IU/l. Serum lipids were within normal limits. In lipoprotein fractions, ~-lipoprotein 
was increased to 79.3%, while a-lipoprotein was decreased to 18.2%. Immunoserologicla 
tests showed an increase of CEA to 8.1 ng/ml, IgG to 2,919 mg/dl, IgA to 574 mg/dl 
and IgE to 447 IU/ml, indicating increased levels of immunoglobulins. Arterial blood 
gas tensions at the time of admission were P02 44 torr and PCO2 35 torr at pH 7.45 
under oxygen inhalation at a rate of 5 1/min.
  
. Table 1. Laboratory data on admission 
Peripheral blood Lipid 
   RBC 571 x 104 T-Chol 204 mg/dl 
   Hb 16.7 g/dl TG 95 mg/dl 
   Ht 49.0 % PL 209 mg/dl 
   WBC 7000 HDL-Chol 26 mg/dl 
    Stab 13 % Free-Chol 51 mg/dl 
    Seg 69 % NEFA 270 mg/dl 
    Eo 2 % Lipoprotein 
     Lymph 9 % Chylomicron 2.4 
    Mono 7 % /3 79.3 
   Plat 36.8 x 104 pre-/3 J 
Blood chemistry a 18.2 
   TP 8.1 g/dl Immunoserological 
    Al 49.5 % CRP (-) 
     al-gl 5.1 % RA (-)
    a2-gl 11.5 % ASLO 80 x 
    /3 -gl 8.5 % CHA 8 x
    r -gl 25.3 % ~ CEA 8.1 ng/ml 
  GOT 96 IU/1 IgG 2919mg/dl 
  GPT 8 IU/1 IgA 574 mg/dl 
  ALP 237 IU/1 IgM 192mg/dl 
  LDH 1430IU/1 IgE 447IU/ml 
   Ch-E 7.6IU/1 ANA (-) 
  Amy 200 U/1 DNA-A 160 
  BUN 8 mg/dl CH50 48 U/ml 
  Cr 1.1 mg/dl /31C-gl 135 mg/dl 
  Na 139 mEq/1 /31E-gl 29.8 mg/dl 
  K 4.8 mEq/1 ESR 69 mm/hr 
  Cl 99 mEq/1 PPD 10x8
     Radiographic reports (Fig. 2) : Chest X-ray film showed diffuse ground-glass 
appearance spreading over all lung fields. Air bronchogram was also observed. The 
silhouettes of the heart and the diaphragm were ill-defined. 
     Clinical course : Bronchoalveolar lavage under general anesthesia was first sched-
uled. However, because of advanced hypoxia, hemipulmonary ventilation was thought 
to be inadequate. On 27th April 1982, the right lung was lavaged by means of massive 
bronchopulmonary lavage with the aid of the partial extracorporeal circulation method 
which removed the blood from the left common ilio-femoral vein and infused the blood 
into the left common ilio-femoral artery and the left subclavicular artery, while the left 
lung was being ventilated with 100% oxygen using a double lumen air duct tube. 
     The lavage solution used for each lavage was a mixture of 900 ml of physiological 
saline, 70 ml of distilled water and 40 ml of 8.4% Meylon, pH being 8.0 and the 
osmotic pressure being 330 mOsm/l. The solution was introduced into the lung by
gravity feeding from the level about 30 cm higher than patient's midchest. Then, the 
chest was lightly tapped with hands and vibrated with a vibrator for about 5 min, and 
the solution was drained by gravity out of the lung into a drain bottle placed at about 
60 cm lower level. These procedures were repeated for 10 times. The total volume of 
the lavage solution introduced was 9,840 mi, and that of the recovered solution was 
10,090 ml. 
     As shown in Fig. 3, the X-ray picture of the chest after the lavage of the right 
lung showed marked improvement. Arterial blood gas tensions were also improved such 
as P02 73 torr, PCO2 40 torr and pH 7.43 under 3 1/min oxygen inhalation. The left 
and right lungs were then lavaged without using extracorporeal circulation. After 3 such 
lavagings, marked improvement was achieved in the chest X-ray pictures (Fig. 4). Ar-
terial blood gas tensions were also improved considerably to be pH 7.46, P02 71 torr, 
PCO2 34 torr, AaD02 38 torr under air inhalation. The patient was discharged on 30th 
June, 1982.
     Respiratory function tests (Table 
2) : The result of the test performed 
before discharge showed % VC of 68.2 
%, indicating restraint disorder, and 
DLCO was decreased to 50.4 %. 
    Pathohistological findings : The 
septum of pulmonary alveoli was mildly 
thickened, alveolar lining cells were swo-
llen, and eosinophilic granular materials 
were packed in the alveoli (Fig. 5). 
The large mononuclear cells alike exfol-
iated alveolar lining cells type II or al-
veolar macrophages were also observed in 
the intraalveolar space (Fig. 6). In other
Table 2. Respiratory function tests 
VC 2340 ml 
  VC 68.2 
FEV 1.0 1990 ml 
FEV1.0% 90.5% 
TV 610 ml 
FRC 1980 ml 
ERV 1240 ml 
RV 740 ml 
TLC 3080 ml 
RV/TLC 24 
V 75 7 1/s 
V 50 2.6 1/s 
V25 1I/s 
DLCO 11.8 m1/min/mmHg 
  DLCO 50.4
biopsy specimen, hyalinized collagen fibers were spiralled, and there was marked deposi-
tion of coal powder around them (Fig. 7). Observation under a polarizing microscope 
showed the presence of considerable numbers of polarizable fine granular materials. 
Therefore, this was thought to be a silicotic nodule. 
     Histochemistry : As shown in Table 3, the granular material and the large mono-
nuclear cell contained in both biopsy specimen and the precipitate of lung lavaged solu-
tion exhibited similar histochemical reactivities. The granular material was most strongly 
positive to PAS staining, and the mononuclear cell also contained PAS-positive substan-
ces. These substances were not digested by a diastase. All lipid stainings tested, i. e. , 
with Oil red 0, Suddan black B and Nile blue, were strongly positive to the large mono-
nuclear cell, and partly positive to the granular material (Fig. 8). Both granular mate-
                 Table 3. Histochemistry 
                            Biopsy specimen Lavage fluid 
                     Granular material Mononuclear cell Granular material Mononuclear cell 
HE + + + + 
PAS -1-f- + -1+ + 
diastase investigation - - - -
Oil red O + -+ + -H-
Sudan black B + ~f- + I f 
Nile blue + -}{- + H 
LFB -F}- + -I-I- + 
Alcian blue - - -!- ± 
Toluidin blue - - ± -
Mucicarmin - - - -
PTAH - - - -
GMS - - - -
rial and mononuclear cell were well stained with LFB staining (for phospholipids), but 
the granular material was strongly positive. Staining with Alcian blue, Toluidine blue 
or Mucicarmin was negative, and that with PTAH was also negative. Pneumocystis car-
inii was denied by GMS staining. 
     Electron microscopic observation : In the intraalveolar space, there were many my-
elin-like materials with a concentric structure and various sizes and shapes, and elec-
tron-opaque bodies with various sizes (Fig. 9). The myelin-like material was formed pri-
marily around the electron-opaque body. Lamellar bodies were also observed, some of 
them being surrounded with the myelin-like materials (Fig. 10). The precipitate of la-
vaged solution also showed similar images. 
     Biochemical analysis of the lavage fluid : A portion of the lavage fluid recovered 
from the lst lavage was centrifuged at 500 x g for 10 min. The grey precipitate with a 
yellowishwhite tint thus obtained was largest in amount in the 1st lavage fluid and de-
creased in subsequent lavage fluids, thus the supernatant became clearer in later lavage 
fluids (Fig. 11). The supernatant and the precipitate of the 1st lavage fluid was supplied 
to biochemical analyses. Proteins were rich (73.1%) in the supernatant, while lipids were
more abundant (65.1%) in the precipitate. 
The proteins consisted of the major pro-
teins of serum such as prealbumin, albu-
min, al-antitrypsin, transferrin and IgG 
(Fig. 12). Lipids in either the super-
natant or the precipitate contained phos-
pholipids abundantly (Tadle 4), in which 
phosphatidylcholin was the highest cons-
tituent (Table 5).
 Table 4. Lipid composition of lavage fluid 
                     Lipid composition
                    (weight %)
                    Supernatant Precipitate 
Phospholipid 72.2 80.8 
Triacylglycerol 0.1 0.8 
Free fatty acid 10.1 1.4 
Total cholesterol 17.5 17.1
          Table 5. Phospholipid composition of lavage fluid 
                                   Phospholipid Composition (mole %) 
Spot No. Lipid 
                                           Supernatant Precipitate 
  I Phosphatidylcholine 35.7 54.9 
  2 Phosphatidylethanolamine 4.5 3.6 
  3 Sphingomyelin 28.6 11.9 
  4 Phosphatidylinositol 0.9 6.4 
  5 Phosphatidylserine 7.5 1.8 
  6 Lysophosphatidylcholine 6.9 6.8 
  7 Unknown - -
  8 Phosphatidylglycerol 2.2 3.2 
  9 Unknown (Glycolipid) - -
 10 Lyso-bis-phosphatidic acid 10.8 7.6 
 11 Unknown (Glycolipid) - -
 12 Unknown (Glycolipid) - -
 13 Unknown (Glycolipid) - -
 14 Unknown (Neutral lipid) - -
 15 Unknown (Neutral lipid) - -
 16 Origin (Degradated lipid) 2.9 3.7
                   DISCUSSION 
      Pulmonary alveolar proteinosis develops regardless of age, but it occurs most fre-
quently at the age between 30-50th, and the incidence in man is twice of that in female. 
Subjective symptoms are exertional dyspnea, cough and sputum. 
     The rise of the LDH level is frequently observed in biochemical blood test. In 
the present case, it was also raised to 1,430 IU/1. Although cases complicated with 
hyperlipemia have been reported4)5), the serum lipid level has been usually reported to 
be normal. The lipoprotein fraction from the serum has been studied by a few inves-
tigators, but the rise of ji-lipoprotein and the decrease of pre-/3-lipoprotein and a-
lipoprotein were demonstrated in the present case. The serum CEA level in the present 
case was as high as 8.1 ng/ml before lavage. Repetitive pulmonary lavages, however, 
decreased the CEA value successively, and it was 2.1 ng/ml at the time of discharge. 
     The chest X-ray film frequently shows fine granular shadow which bilaterally 
spread from the hilus. Such a shadow is sometimes described as frosted glass-like or 
cloud-like shadow, air bronchogram is frequently observed, which is thought to be due 
to dense and fine granular alveolar shadow. 
     Pulmonary function tests show restraint disorder and lowered DLCO. Blood gas 
analysis reveals hypoxemia and increased AaDO2. The present case also showed marked 
hypoxemia and the increase of AaDO2. Although these symptoms were improved by 
pulmonary lavage, respiratory function tests before discharge indicated the presence of 
restraint disorder and lowered DLCO. Since this particular case had pulmonary silicosis
and tuberculosis as basal diseases, their influence may not be ignored. It was also 
conceivable that protein-like material accumulated in the intraalveolar space had not been 
completely eliminated. 
      Regarding the complication of pulmonary alveolar proteinosis with pulmonary sill-
cosis, 6 cases have been reported in Japan, and one case out of 27 cases reported by 
ROSEN et al.1) also experienced the inhalation of silica. In 1969 BUECHNER et al .7) 
described 4 cases in which acute silicosis and pulmonary alveolar proteinosis were com-
plicated. The term given by him to these dead cases was `acute silico-proteinosis' . 
Although experimental inhalation of silica by animals may produce the morbid image 
similar to pulmonary alveolar proteinosis8), the inhalation of silica can be one of inducing 
factors. However, many other cases are entirely unrealated to silica inhalation. There-
fore, it is unlikely that the inhalation of silica is a direct cause of pulmonary alveolar 
proteinosis. 
     Pathohistological characteristic of the proteinosis is the presence of eosinophilic 
granular materials which fill the intraalveolar space. The existence of the large mono-
nuclear cells appeared to be exfoliated alveolar lining cells type II or alveolar macrophages 
are also characteristics. The alveolar septum is mildly thickened. The proliferation of 
the alveolar lining cells type If is present in some region and absent in the other. 
These regions were classified by OKADA et al.9), based on electron microscopic obser-
vation, to be the area of desquamation and sloughing and the area of accumulation. 
     Histochemical findings in the present case mostly agreed with those reported by 
other investigators')') 10) . Granular materials were strongly stained with PAS and LFB, 
thus they were thought to be phospholipid-rich proteins. Large mononuclear cells were 
strongly positive to lipid stainings such as Oil red 0, Suddan black B and Nile blue 
stainings, indicating the high content of neutral lipids. 
      Electron microscopic observation showed the presence of electron-opaque bodies 
with various sizes and of myelin-like structures, the former being surrounded by the 
latter. Lamellar bodies were also observed, and some of the electron-opaque bodies were 
surrounded by such lamellar bodies. ROSEN et al.1) and OKADA et al.9) have stated 
that the material accumulated in the intraalveolar space is that formed by the decompo-
sition of alveolar lining cells type 0 . Electron microscopic observation of ours also 
suggested degenerated and decomposed alveolar lining cells type If or degenerated lung 
surfactants to be the origin of the accumulated material. 
     Biochemical analysis of the lavage fluid showed the abundancy of lipids in the 
precipitate and of proteins in the supernatant. Although the phospholipid was the major 
constituent of the lipid, the supernatant had different phospholipid composition from the 
precipitate. In the supernatant, phosphatidylcholine and sphingomyelin were major, while 
phosphatidylcho line was high and sphingomyelin was low in the precipitate. It has been 
stated by AKINO et al.11) that the phospholipid in the precipitate is mostly derived from 
the lung surfactant secrected from the alveolar cells type f , rather than derived from 
intraalveolar free cells. According to a study using radioactive isotopes, there is no
particular facilitation of the synthesis of phosphatidylcholine, though the synthesis of 
this phospholipid de novo and via the lysolecithin formation system is basically active in 
the lung tissue from a patient with pulmonary alveolar proteinosis. Moreover, the se-
cretion of phosphatidylcho line into the intraalveolar space is not known to be facilitated. 
Therefore, it may be thought that disturbed removal mechanism is responsible for the 
accumulation of surfactant-origin lipids in the intraalveolar space.
                   CONCLUSION 
     A case of pulmonary alveolar proteinosis developed as a complication of pulmonary 
silicosis was reported. The patient was saved by bronchoalveolar lavage with the aid of 
extracorporeal circulation, because of advanced dyspnea. On the basis of pathohistologi-
cal, histochemical and electron microscopic observations and of biochemical analyses, it 
was thought that the material accumulated in the intraalveolar space was mostly originated 
from the lung surfactant secreted by the pulmonary alveolar cells type I .
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Fig. 1 Chest roentgenogram of 8th March, 1982 
      shows diffuse fine granular shadow 
     through out lung fields.
Fig. 2 Chest roentgenogram of 21th April, 1982 
      shows slight increase in pulmonary inf-
      iltrates.
Fig. 3 Chest roentgenogram of 13th May, 1982, 
     16 days after lavage of the right lung, 
      shows considerable clearing of that lung.
Fig. 4 Chest roentgenogram of 25th May, 1982, 
      after three lavages, shows dramatic cle-
     aring bilaterally.
Fig. 5 Biopsy specimen obtained at transbronchial biopsy. 
      The alveolar space are filled with eosinophilic granular 
      materials typical of pulmonary alveolar proteinosis.
Fig. 6 High magnification. The large mononuclear cells are seen 
      in the intraalveolar space and the alveolar lining cells 
      are swollen.
Fig. 7 Hyalinized collagen fiber and anthracosis are seen. Fig. 8 Numerous red granules are seen in the alveolar macro-
    phage, (Oil red 0 stain).
Fig. 9 Electron micrograph of bronchoalveolar lavage fluid (13,000x). The electron-
        opaque bodies and the myelin-like materials surrounding them are observed.
Fig. 10 Electron micrograph of bronchoalveolar lavage fluid (10,000x). The extracellular 
        lamellar bodies surrounded by myelin-like materials are observed.
Fig. 11 A portion of the lavage fluid from Ist lavage was centrifuged 




Light Chain L 
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Fig. 12 Immunoelectrophoresis revealed the major proteins of serum such 
       as prealbumin, albumin, al-antitrypsin, transferrin and IgG.
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